Tajikistan Tuberculosis (TB) Bilateral Activity
ID: 72011922RFA00001 • Type: Posted
Overview
Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 5/17/22 U.S. Agency for International Development posted grant opportunity 72011922RFA00001 for Tajikistan Tuberculosis (TB) Bilateral Activity with funding of $20.7 million.
The grant will be issued under grant program 98.001 USAID Foreign Assistance for Programs Overseas.
It is expected that one grant will be made
worth between $1 and $20.7 million.
Timing
Posted Date
May 17, 2022, 12:00 a.m. EDT
Closing Date
July 22, 2022, 12:00 a.m. EDT Past Due
Last Updated
June 23, 2022, 1:27 a.m. EDT
Version
3
Archive Date
Aug. 21, 2022
Eligibility
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Award Sizing
Ceiling
$20,673,753
Floor
$1
Estimated Program Funding
$20,673,753
Estimated Number of Grants
1
Contacts
Contact
Dauren Akhmetov
Grantor
Contact Email
dakhmetov@usaid.gov   Profile
Email Description
Work e-mail
Contact Phone
87010916227